Ligand Pharmaceuticals Incorporated (LGND)

Healthcare · Biotechnology · NASDAQ

Ligand Pharmaceuticals Incorporated (LGND) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $6.36B, a trailing price-to-earnings ratio of 32.2 and a free-cash-flow yield of 0.6%. Over the most recent reported fiscal year, revenue grew 60.4% and free cash flow per share fell 55.7%.

Market cap	$6.36B
Trailing P/E	32.2
FCF yield	0.6%
Revenue growth (YoY)	+60.4%
EPS growth (YoY)	+40.8%
FCF/share growth (YoY)	-55.7%
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live LGND data on Nama Insights →

Recent Congressional trades

Ligand Pharmaceuticals Incorporated trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Jun 5, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Feb 11, 2026
Katherine M. Clark	House	Buy	$1,001 - $15,000	May 21, 2020